| Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ... New England journal of medicine 334 (18), 1150-1155, 1996 | 4655 | 1996 |
| Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SM Lippman, EA Klein, PJ Goodman, MS Lucia, IM Thompson, LG Ford, ... Jama 301 (1), 39-51, 2009 | 2762 | 2009 |
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, ... Jama 306 (14), 1549-1556, 2011 | 2218 | 2011 |
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ... JNCI: Journal of the National Cancer Institute 88 (21), 1550-1559, 1996 | 1579 | 1996 |
| Polyamines and cancer: old molecules, new understanding EW Gerner, FL Meyskens Jr Nature Reviews Cancer 4 (10), 781-792, 2004 | 1357 | 2004 |
| Reactive oxygen species: a breath of life or death? JP Fruehauf, FL Meyskens Jr Clinical Cancer Research 13 (3), 789-794, 2007 | 1163 | 2007 |
| Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement J Cuzick, F Otto, JA Baron, PH Brown, J Burn, P Greenwald, J Jankowski, ... The lancet oncology 10 (5), 501-507, 2009 | 876 | 2009 |
| Development of difluoromethylornithine (DFMO) as a chemoprevention agent FL Meyskens Jr, EW Gerner Clinical Cancer Research 5 (5), 945-951, 1999 | 826 | 1999 |
| Retinoids as preventive and therapeutic anticancer agents (Part I). SM Lippman, JF Kessler, FL Meyskens Jr Cancer treatment reports 71 (4), 391-405, 1987 | 638* | 1987 |
| Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy HCF Moore, JM Unger, KA Phillips, F Boyle, E Hitre, D Porter, PA Francis, ... New England Journal of Medicine 372 (10), 923-932, 2015 | 613 | 2015 |
| Prevention and early detection of prostate cancer J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ... The lancet oncology 15 (11), e484-e492, 2014 | 603 | 2014 |
| Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia RE Carroll, RV Benya, DK Turgeon, S Vareed, M Neuman, L Rodriguez, ... Cancer prevention research 4 (3), 354-364, 2011 | 583 | 2011 |
| Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial FL Meyskens Jr, CE McLaren, D Pelot, S Fujikawa-Brooks, PM Carpenter, ... Cancer prevention research 1 (1), 32-38, 2008 | 574 | 2008 |
| Rationale and strategies for chemoprevention of cancer in humans JS Bertram, LN Kolonel, FL Meyskens Jr Cancer research 47 (11), 3012-3031, 1987 | 562 | 1987 |
| The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol … GE Goodman, MD Thornquist, J Balmes, MR Cullen, FL Meyskens Jr, ... Journal of the National Cancer Institute 96 (23), 1743-1750, 2004 | 557 | 2004 |
| Quality of life end points in cancer clinical trials: review and recommendations CMM Moinpour, P Feigl, B Metch, KA Hayden, FL Meyskens Jr, J Crowley JNCI: Journal of the National Cancer Institute 81 (7), 485-496, 1989 | 497 | 1989 |
| Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development: recommendations of the American association for cancer … JA O’Shaughnessy, GJ Kelloff, GB Gordon, AJ Dannenberg, WK Hong, ... Clinical Cancer Research 8 (2), 314-346, 2002 | 447 | 2002 |
| Ki-ras Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study DJ Ahnen, P Feigl, G Quan, C Fenoglio-Preiser, LC Lovato, PA Bunn Jr, ... Cancer research 58 (6), 1149-1158, 1998 | 443 | 1998 |
| Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial TM Brasky, AK Darke, X Song, CM Tangen, PJ Goodman, IM Thompson, ... Journal of the National Cancer Institute 105 (15), 1132-1141, 2013 | 440 | 2013 |
| Estimates of benefits and harms of prophylactic use of aspirin in the general population J Cuzick, MA Thorat, C Bosetti, PH Brown, J Burn, NR Cook, LG Ford, ... Annals of Oncology 26 (1), 47-57, 2015 | 439 | 2015 |
